| 3022 |
2172: Activated Wnt/Frizzled pathway |
1928: increased,Vascular endothelial dysfunction |
Aug 21, 2023 |
Aug 21, 2023 |
1 AOP
|
| 1559 |
1421: Activated, LXR |
1422: Reduced, PPARalpha |
Jun 2, 2017 |
Jun 2, 2017 |
1 AOP
|
| 1458 |
1355: Activated, membrane depolarization |
1362: Increased, hippocampal hyperdepolarization |
Apr 14, 2017 |
Apr 14, 2017 |
3 AOPs
|
| 1454 |
1351: Activated, NMDA receptor |
1321: Increased, intracellular sodium (Na+) |
Apr 14, 2017 |
Apr 14, 2017 |
2 AOPs
|
| 1452 |
1349: Activated, presynaptic neuron 1 |
1350: Increased, glutamate |
Apr 14, 2017 |
Apr 14, 2017 |
2 AOPs
|
| 3086 |
1349: Activated, presynaptic neuron 1 |
1018: Activation, Glutamate-gated chloride channels |
Oct 17, 2023 |
Oct 17, 2023 |
1 AOP
|
| 3088 |
1349: Activated, presynaptic neuron 1 |
1177: Decreased, Ionotropic GABA receptor chloride channel conductance |
Oct 17, 2023 |
Oct 17, 2023 |
1 AOP
|
| 1457 |
1352: Activated, voltage-gated sodium channel |
1355: Activated, membrane depolarization |
Apr 14, 2017 |
Apr 14, 2017 |
2 AOPs
|
| 2996 |
2169: Activation of Angiogenic cytokines |
1928: increased,Vascular endothelial dysfunction |
Aug 20, 2023 |
Aug 20, 2023 |
1 AOP
|
| 2995 |
2168: Activation of angiopoietin like protein 4 |
1928: increased,Vascular endothelial dysfunction |
Aug 20, 2023 |
Aug 20, 2023 |
1 AOP
|
| 2705 |
2038: Activation, calpain |
1825: Increase, Cell death |
Jul 25, 2022 |
Jul 25, 2022 |
1 AOP
|
| 1610 |
1448: activation of CEBPA |
1028: Activation of specific nuclear receptors, PPAR-gamma activation |
Jul 24, 2017 |
Jul 24, 2017 |
1 AOP
|
| 1611 |
1448: activation of CEBPA |
1449: increased adipogenesis |
Jul 24, 2017 |
Jul 24, 2017 |
1 AOP
|
| 1512 |
1391: Activation of Cyp2E1 |
1392: Increase, Oxidative Stress |
May 30, 2017 |
Jul 1, 2021 |
2 AOPs
|
| 1515 |
1391: Activation of Cyp2E1 |
1393: Hepatocytotoxicity |
May 30, 2017 |
Dec 6, 2018 |
1 AOP
|
| 2673 |
2009: Activation, inflammation pathway |
2010: Pulmonary inflammation |
Jun 17, 2022 |
Jun 17, 2022 |
1 AOP
|
| 2981 |
2009: Activation, inflammation pathway |
1928: increased,Vascular endothelial dysfunction |
Aug 19, 2023 |
Aug 19, 2023 |
2 AOPs
|
| 3006 |
2009: Activation, inflammation pathway |
2175: Endothelial cell death |
Aug 21, 2023 |
Aug 21, 2023 |
None
|
| 3007 |
2009: Activation, inflammation pathway |
2176: Decreased endothelial cell proliferation |
Aug 21, 2023 |
Aug 21, 2023 |
None
|
| 3008 |
2009: Activation, inflammation pathway |
1472: Decrease, ATP production |
Aug 21, 2023 |
Aug 21, 2023 |
None
|
| 3009 |
2009: Activation, inflammation pathway |
2161: Increase, Vascular disrupting effects |
Aug 21, 2023 |
Aug 21, 2023 |
None
|
| 2701 |
2036: Activation, mGLUr |
389: Increased, Intracellular Calcium overload |
Jul 25, 2022 |
Jul 25, 2022 |
None
|
| 2703 |
2036: Activation, mGLUr |
2037: Activation, IP3R |
Jul 25, 2022 |
Jul 25, 2022 |
1 AOP
|
| 2942 |
2146: Activation of MEK, ERK1/2 |
1339: Increase, intracellular calcium |
Jun 20, 2023 |
Apr 11, 2024 |
2 AOPs
|
| 2994 |
2167: Activation of MMP-2 MMP-9 |
1928: increased,Vascular endothelial dysfunction |
Aug 20, 2023 |
Aug 20, 2023 |
1 AOP
|